Regenerative medicine technologies applied to transplant medicine. An update

Regenerative medicine (RM) is changing how we think and practice transplant medicine. In regenerative medicine, the aim is to develop and employ methods to regenerate, restore or replace damaged/diseased tissues or organs. Regenerative medicine investigates using tools such as novel technologies or...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in bioengineering and biotechnology Vol. 10; p. 1015628
Main Authors Petrosyan, Astgik, Montali, Filippo, Peloso, Andrea, Citro, Antonio, Byers, Lori N., La Pointe, Catherine, Suleiman, Mara, Marchetti, Alice, Mcneill, Eoin P., Speer, Allison L, Ng, Wai Hoe, Ren, Xi, Bussolati, Benedetta, Perin, Laura, Di Nardo, Paolo, Cardinale, Vincenzo, Duisit, Jerome, Monetti, Alexandra Rose, Savino, John Richard, Asthana, Amish, Orlando, Giuseppe
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 28.09.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Regenerative medicine (RM) is changing how we think and practice transplant medicine. In regenerative medicine, the aim is to develop and employ methods to regenerate, restore or replace damaged/diseased tissues or organs. Regenerative medicine investigates using tools such as novel technologies or techniques, extracellular vesicles, cell-based therapies, and tissue-engineered constructs to design effective patient-specific treatments. This review illustrates current advancements in regenerative medicine that may pertain to transplant medicine. We highlight progress made and various tools designed and employed specifically for each tissue or organ, such as the kidney, heart, liver, lung, vasculature, gastrointestinal tract, and pancreas. By combing both fields of transplant and regenerative medicine, we can harbor a successful collaboration that would be beneficial and efficacious for the repair and design of de novo engineered whole organs for transplantations.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Reviewed by: Toshiharu Shinoka, Nationwide Children’s Hospital, United States
Paolo De Coppi, University College London, United Kingdom
Ivan Martin, University of Basel, Switzerland
Edited by: Ranieri Cancedda, Independent researcher, Genova, Italy
This article was submitted to Tissue Engineering and Regenerative Medicine, a section of the journal Frontiers in Bioengineering and Biotechnology
ISSN:2296-4185
2296-4185
DOI:10.3389/fbioe.2022.1015628